Coronavirus disease 2019 (COVID-19) is a pandemic syndrome caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. SARS-CoV-2 infection induces a process of inflammation and thrombosis supported by an altered platelet activation state. This platelet activation is peculiar being characterized by the formation of platelet-leukocytes rather than platelet-platelet aggregates and by an increased procoagulant potential supported by elevated levels of TF positive platelets and microvesicles. Therapeutic strategies targeting, beyond systemic inflammation (i.e. with tocilizumab, an anti interleukin-6 receptor), this state of platelet activation might therefore be beneficial. Among the antithrombotic drugs proposed as candidates to treat patients with SARS-CoV-2 infection, antiplatelet drugs, such as aspirin are showing promising results.

No abstract

No abstract

No abstract

If there are any concerns regarding these charges, these should be addressed within 48 hours of receiving the s-proof. Author(s) will be invoiced for all color and page charges post publication. If you have selected open access for your article, please refer to details in the queries below. AUTHOR PLEASE ANSWER ALL QUERIESAQ1-Please confirm that all authors are included in the correct order in the byline and that all names are spelled correctly, including special characters, accents, middle initials, and degrees, if applicable. For indexing purposes, confirm author names have been correctly identified as given names (blue), surnames (red), and suffixes (black). Color in the byline will not appear on the final published version. Note that journal style discourages listing honorary degrees (FAHA, FRCP, etc.) in the byline; please delete such degrees from the author byline. AQ2-Per style, quotes should not be used for emphasis. Hence, they have been deleted throughout the article. Please confirm whether the change made throughout is appropriate. AQ3-Please define "SARS-CoV2" in text. AQ4-Please confirm that all authors' institutional affiliations (including city/state/country locations) are correct as shown in the affiliations footnote. AQ5-Please provide the department for the affiliation "Centro Cardiologico Monzino IRCCS" if applicable. AQ6-Please carefully review any Acknowledgments, Sources of Funding, and/or Disclosures listed at the end of the manuscript (before the References), and confirm that they are accurate and complete for all authors.